医学
食品药品监督管理局
连续血糖监测
药品管理局
糖尿病
重症监护医学
顺从(心理学)
药品
药理学
1型糖尿病
内分泌学
心理学
社会心理学
作者
Peter Stephan,Manuel Eichenlaub,Delia Waldenmaier,Stefan Pleus,Martina Rothenbühler,Cornelia Haug,Guido Freckmann
出处
期刊:Diabetes Technology & Therapeutics
[Mary Ann Liebert]
日期:2023-03-01
卷期号:25 (3): 212-216
被引量:4
标识
DOI:10.1089/dia.2022.0331
摘要
To assess the compliance of “integrated” continuous glucose monitoring (CGM) systems with U.S. Food and Drug Administration requirements, the calculation of confidence intervals (CIs) on agreement rates (ARs), that is, the percentage of CGM measurements lying within a certain deviation of a comparator method, is stipulated. However, despite the existence of numerous approaches that could yield different results, a specific procedure for calculating CIs is not described anywhere. This report, therefore, proposes a suitable statistical procedure to allow transparency and comparability between CGM systems. Three existing methods were applied to six data sets from different CGM performance studies. The results indicate that a bootstrap-based method that accounts for the clustered structure of CGM data is reliable and robust. We thus recommend its use for the estimation of CIs of ARs. A software implementation of the proposed method is freely available (https://github.com/IfDTUlm/CGM_Performance_Assessment).
科研通智能强力驱动
Strongly Powered by AbleSci AI